Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00487058
Status:
COMPLETED
Last Update Posted:
2009-11-19
First Post:
2007-06-14
Brief Title:
A Phase I Dose Escalation Study of LBQ707 Gimatecan Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors
Sponsor:
Organization:
Novartis